SI-BONE, Inc. (SIBN)
NASDAQ: SIBN · IEX Real-Time Price · USD
13.00
+0.10 (0.78%)
Jul 2, 2024, 4:00 PM EDT - Market closed
SI-BONE Market Cap
SI-BONE has a market cap or net worth of $535.66 million as of July 2, 2024. Its market cap has decreased by -47.25% in one year.
Market Cap
535.66M
Enterprise Value
416.57M
1-Year Change
-47.25%
Ranking
Category
Stock Price
$13.00
Market Cap Chart
Since October 17, 2018, SI-BONE's market cap has increased from $437.20M to $535.66M, an increase of 22.52%. That is a compound annual growth rate of 3.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 531.50M | -37.48% |
| Dec 29, 2023 | 850.10M | 81.18% |
| Dec 30, 2022 | 469.20M | -36.92% |
| Dec 31, 2021 | 743.80M | -23.13% |
| Dec 31, 2020 | 967.60M | 79.99% |
| Dec 31, 2019 | 537.60M | 5.74% |
| Dec 31, 2018 | 508.40M | 16.29% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 542.12M |
| Contineum Therapeutics | 540.19M |
| SIGA Technologies | 536.97M |
| Annexon | 532.34M |
| Entrada Therapeutics | 531.64M |
| Adaptive Biotechnologies | 530.52M |
| Corbus Pharmaceuticals Holdings | 527.92M |
| Third Harmonic Bio | 527.84M |